MOL4239

· Moleculin, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MOL4239, covering 2014-12-24 to 2014-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis [Phase 2]